LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article: [Analysis of the changes of inflammatory cytokine levels in patients with critical coronavirus disease 2019 undergoing invasive mechanical ventilation].

    Shan, Hongwei / Lyu, Zheng / Xiao, Yan / Li, Chunyang / Wang, Jian / He, Liping / Chen, Fengying

    Zhonghua wei zhong bing ji jiu yi xue

    2020  Volume 32, Issue 9, Page(s) 1051–1055

    Abstract: ... prognosis of patients with critical coronavirus disease 2019 (COVID-19) undergoing invasive ... Objective: To investigate the relationship between the changes of inflammatory cytokine levels and ... undergoing IMV (all P < 0.05).: Conclusions: The levels of inflammatory cytokine including IL-6, IL-10 ...

    Abstract Objective: To investigate the relationship between the changes of inflammatory cytokine levels and prognosis of patients with critical coronavirus disease 2019 (COVID-19) undergoing invasive mechanical ventilation (IMV).
    Methods: A retrospective study was conducted. The clinical date of critical COVID-19 patients undergoing IMV who were hospitalized in Wuhan Union Hospital, Tongji Medical College of Huazhong University of Science and Technology from February 4th to March 25th in 2020 were collected. At the same time, the inflammatory cytokine levels including interleukins (IL-2, IL-4, IL-6, IL-10) and tumor necrosis factor-α (TNF-α) at 48 hours before IMV and 48 hours after IMV of all the patients, as well as the 48 hours after weaning or right before death were recorded. Multivariate unconditional Logistic regression analysis was used to screen the independent risk factors of death during hospitalization.
    Results: Among the 43 patients, 13 patients improved and 30 died. Compared with the survival group, the patients in the non-survival group were older (years old: 67.6±7.3 vs. 58.5±11.9, P < 0.05), with higher rates of hypertension, diabetes and coronary heart disease (53.3% vs. 15.4%, 63.3% vs. 23.1%, 26.7% vs. 0%, all P < 0.05), and the time from onset to admission to hospital, admission to ICU and IMV were longer (days: it was 9.17±5.00 vs. 5.07±2.49, 17.10±7.11 vs. 12.23±5.05, and 17.90±7.46 vs. 12.61±5.60, respectively, all P < 0.05). The IL-6 and TNF-α levels on 48 hours after IMV in the non-survival patients increased significantly as compared with those before 48 hours and the surviving patients. Especially, the IL-6 levels increased significantly as compared with those at 48 hours after IMV and 48 hours after weaning in the surviving patients [ng/L: 800.00 (194.25, 2 000.00) vs. 22.03 (6.66, 28.21), 3 204.00 (1 264.88, 5 000.00) vs. 5.00 (3.98, 12.27), both P < 0.01]. The IL-10 level before death in the non-survival patients increased significantly as compared with that at 48 hours after weaning in the surviving patients [ng/L: 55.89 (26.07, 100.14) vs. 3.53 (2.76, 12.36), P < 0.05]. There were no significant differences in the levels of IL-2 and IL-4 between the two groups at every time point. The variables of age, basic diseases, the IL-6 level after IMV were included in the multivariate unconditional Logistic regression analysis, which showed that age [odds ratio (OR) = 0.821, 95% confidence interval (95%CI) was 0.695-0.968], hypertension (OR = 0.027, 95%CI was 0.002-0.378), diabetes mellitus (OR = 0.054, 95%CI was 0.005-0.611), coronary heart disease (OR = 0.042, 95%CI was 0.002-0.968) and the IL-6 level after IMV (OR = 0.902, 95%CI was 0.819-0.994) were independent risk factors for death during hospitalization in patients with critical COVID-19 undergoing IMV (all P < 0.05).
    Conclusions: The levels of inflammatory cytokine including IL-6, IL-10, and TNF-α increased significantly with aggravation in critical COVID-19 patients undergoing IMV, especially IL-6. IL-6 was an independent risk factor for death of critical COVID-19 patients undergoing IMV.
    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus Infections/therapy ; Cytokines ; Humans ; Pandemics ; Pneumonia, Viral/therapy ; Respiration, Artificial ; Retrospective Studies ; SARS-CoV-2
    Chemical Substances Cytokines
    Keywords covid19
    Language Chinese
    Publishing date 2020-10-21
    Publishing country China
    Document type Journal Article
    ISSN 2095-4352
    ISSN 2095-4352
    DOI 10.3760/cma.j.cn121430-20200414-00519
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: [Analysis of the changes of inflammatory cytokine levels in patients with critical coronavirus disease 2019 undergoing invasive mechanical ventilation]

    Shan, H. / Lyu, Z. / Xiao, Y. / Li, C. / Wang, J. / He, L. / Chen, F.

    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue

    Abstract: ... prognosis of patients with critical coronavirus disease 2019 (COVID-19) undergoing invasive ... mechanical ventilation (IMV) METHODS: A retrospective study was conducted The clinical date of critical COVID-19 patients ... OBJECTIVE: To investigate the relationship between the changes of inflammatory cytokine levels and ...

    Abstract OBJECTIVE: To investigate the relationship between the changes of inflammatory cytokine levels and prognosis of patients with critical coronavirus disease 2019 (COVID-19) undergoing invasive mechanical ventilation (IMV) METHODS: A retrospective study was conducted The clinical date of critical COVID-19 patients undergoing IMV who were hospitalized in Wuhan Union Hospital, Tongji Medical College of Huazhong University of Science and Technology from February 4th to March 25th in 2020 were collected At the same time, the inflammatory cytokine levels including interleukins (IL-2, IL-4, IL-6, IL-10) and tumor necrosis factor-α (TNF-α) at 48 hours before IMV and 48 hours after IMV of all the patients, as well as the 48 hours after weaning or right before death were recorded Multivariate unconditional Logistic regression analysis was used to screen the independent risk factors of death during hospitalization RESULTS: Among the 43 patients, 13 patients improved and 30 died Compared with the survival group, the patients in the non-survival group were older (years old: 67 6±7 3 vs 58 5±11 9, P < 0 05), with higher rates of hypertension, diabetes and coronary heart disease (53 3% vs 15 4%, 63 3% vs 23 1%, 26 7% vs 0%, all P < 0 05), and the time from onset to admission to hospital, admission to ICU and IMV were longer (days: it was 9 17±5 00 vs 5 07±2 49, 17 10±7 11 vs 12 23±5 05, and 17 90±7 46 vs 12 61±5 60, respectively, all P < 0 05) The IL-6 and TNF-α levels on 48 hours after IMV in the non-survival patients increased significantly as compared with those before 48 hours and the surviving patients Especially, the IL-6 levels increased significantly as compared with those at 48 hours after IMV and 48 hours after weaning in the surviving patients [ng/L: 800 00 (194 25, 2 000 00) vs 22 03 (6 66, 28 21), 3 204 00 (1 264 88, 5 000 00) vs 5 00 (3 98, 12 27), both P < 0 01] The IL-10 level before death in the non-survival patients increased significantly as compared with that at 48 hours after weaning in the surviving patients [ng/L: 55 89 (26 07, 100 14) vs 3 53 (2 76, 12 36), P < 0 05] There were no significant differences in the levels of IL-2 and IL-4 between the two groups at every time point The variables of age, basic diseases, the IL-6 level after IMV were included in the multivariate unconditional Logistic regression analysis, which showed that age [odds ratio (OR) = 0 821, 95% confidence interval (95%CI) was 0 695-0 968], hypertension (OR = 0 027, 95%CI was 0 002-0 378), diabetes mellitus (OR = 0 054, 95%CI was 0 005-0 611), coronary heart disease (OR = 0 042, 95%CI was 0 002-0 968) and the IL-6 level after IMV (OR = 0 902, 95%CI was 0 819-0 994) were independent risk factors for death during hospitalization in patients with critical COVID-19 undergoing IMV (all P < 0 05) CONCLUSIONS: The levels of inflammatory cytokine including IL-6, IL-10, and TNF-α increased significantly with aggravation in critical COVID-19 patients undergoing IMV, especially IL-6 IL-6 was an independent risk factor for death of critical COVID-19 patients undergoing IMV
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #883888
    Database COVID19

    Kategorien

To top